Hamlet BioPharma AB
HAMLET | SPGR
Overview
Corporate Details
- ISIN(s):
- SE0015661145 (+2 more)
- LEI:
- 549300HJV2LJY4CDBR64
- Country:
- Sweden
- Address:
- Klinikgatan 32, 222 42 LUND
- Website:
- https://hamletbiopharma.com/
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
Hamlet BioPharma is a pharmaceutical company. Most research and development is carried out in the field of protein-lipid complexes, which are used in the treatment of various forms of cancer. The company has developed a tumoricidal protein-lipid complex that mainly is used in the treatment of breast cancer, bladder cancer, as well as in cases of cancer that are hard to treat. The company is based in Lund.
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Idorsia Ltd | Switzerland | IDIA | |
|
ILIKA PLC | United Kingdom | IGE | |
|
Indivior PLC | United Kingdom | INDV | |
|
Infant Bacterial Therapeutics | Sweden | IBT | |
|
Initiator Pharma A/S | Denmark | INIT | |
|
Intercure Ltd. | Israel | INCR | |
|
Intervacc AB | Sweden | IVACC | |
|
Ipsen | France | IPN | |
|
J. Molner AS | Estonia | JML | |
|
KANABO GROUP PLC | United Kingdom | KNB |